These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7501966)

  • 1. A toxicologic pathologist's view of apoptosis or I used to call it necrobiosis, but now I'm singing the apoptosis blues.
    Levin S
    Toxicol Pathol; 1995; 23(4):533-9. PubMed ID: 7501966
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicologic pathology in the new millennium.
    Ettlin RA; Leininger JR
    Toxicol Pathol; 2002; 30(1):160-3. PubMed ID: 11890471
    [No Abstract]   [Full Text] [Related]  

  • 3. The re-emergence (or the decline) of toxicologic pathology.
    Alden CL
    Toxicol Pathol; 2009 Aug; 37(5):570-1. PubMed ID: 19638439
    [No Abstract]   [Full Text] [Related]  

  • 4. A brief review of modern toxicologic pathology in regulatory and explanatory toxicity studies of chemicals.
    Ettlin RA; Oberholzer M; Perentes E; Ryffel B; Kolopp M; Qureshi SR
    Arch Toxicol; 1991; 65(6):445-53. PubMed ID: 1929864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A personal perspective on the past, present, and future of Toxicologic Pathology.
    Trump BF
    Toxicol Pathol; 1997; 25(4):426-8. PubMed ID: 9280134
    [No Abstract]   [Full Text] [Related]  

  • 6. Modern imaging technologies in toxicologic pathology: An overview.
    Ying X; Monticello TM
    Toxicol Pathol; 2006; 34(7):815-26. PubMed ID: 17178685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicologic pathology: looking ahead.
    Schwetz BA
    Toxicol Pathol; 2003; 31 Suppl():2-5. PubMed ID: 12597424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: comments on the cell death nomenclature recommendations of the Society of Toxicologic Pathologists.
    Mohr U
    Toxicol Pathol; 1999; 27(4):497. PubMed ID: 10485841
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of environmental and toxicologic pathology.
    Wagner BM
    Hum Pathol; 1996 Oct; 27(10):1003-4. PubMed ID: 8892580
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: implementation of the STP recommendations on the nomenclature of cell death. Society of Toxicologic Pathologists.
    Levin S
    Toxicol Pathol; 1999; 27(4):491. PubMed ID: 10485837
    [No Abstract]   [Full Text] [Related]  

  • 11. Response letter from Clinical Pathology Interest Group of the Society of Toxicologic Pathology (STP) for manuscript entitled International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et al.
    Tripathi NK; Schultze AE; Pearson RC; Everds NE; Elliott GS; Ramaiah L; Wells MY; Latimer KS; Walter GL; Katavolos P; Collins ND; Tarrant J; Walker DB; Topper MJ; Jordan HL; O'Rourke LG; Guilpin VB; Brockus CW; Wilcox AL; Clemo FA; Smith GS; Reagan WJ; McCartney JE
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):39. PubMed ID: 21676604
    [No Abstract]   [Full Text] [Related]  

  • 12. The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists.
    Levin S; Bucci TJ; Cohen SM; Fix AS; Hardisty JF; LeGrand EK; Maronpot RR; Trump BF
    Toxicol Pathol; 1999; 27(4):484-90. PubMed ID: 10485836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, necrosis, or oncosis: what is your diagnosis? A report from the Cell Death Nomenclature Committee of the Society of Toxicologic Pathologists.
    Levin S
    Toxicol Sci; 1998 Feb; 41(2):155-6. PubMed ID: 9520350
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicologic pathology in the 21st century.
    Ettlin RA
    Toxicol Pathol; 2013 Jul; 41(5):689-708. PubMed ID: 23143188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on application of refined morphologic evaluation of the testis to the practice of toxicologic pathology.
    Szczech GM; Russell LD
    Toxicol Pathol; 1997; 25(2):230-7. PubMed ID: 9125783
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicologic Pathology Forum*: Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma.
    Gopinath C; Mowat V
    Toxicol Pathol; 2019 Jul; 47(5):564-573. PubMed ID: 31291835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Considerations and Evolving Technologies in Toxicologic Pathology. Proceedings of the Society of Toxicologic Pathologists 12th International Symposium. Alexandria, Virginia, June 27-July 1, 1993.
    Toxicol Pathol; 1994; 22(2):85-225. PubMed ID: 7973373
    [No Abstract]   [Full Text] [Related]  

  • 18. Career Transition Points in Toxicologic Pathology: Management and Consulting.
    Choudhary S; Osborne T; Adler RR; McDorman KS; Dillberger JE; Ochoa R
    Toxicol Pathol; 2017 Oct; 45(7):1012-1021. PubMed ID: 29020890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicologic Pathology Forum*: Commentary on "Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma".
    Patrick DJ; Troth SP
    Toxicol Pathol; 2019 Jul; 47(5):574-576. PubMed ID: 31303126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tox/Path team takes on differential gene expression.
    Cunningham ML; Irwin R; Boorman G
    Environ Health Perspect; 2003 Nov; 111(15):A814-5. PubMed ID: 14630520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.